MARKET WIRE NEWS
  1. Home
  2. Stock
  3. DMAC
  4. News
DMAC
Quote
Short
News
Articles
Message Board

DiaMedica Therapeutics Inc. (NASDAQ : DMAC ) News

News Releases

DMAC News Releases
DMAC : NASDAQ
Business Wire
DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction
DMAC : NASDAQ
Business Wire
DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program
DMAC : NASDAQ
Motley Fool
DiaMedica (DMAC) Q4 2025 Earnings Transcript
DMAC : NASDAQ
Business Wire
DiaMedica Therapeutics to Present at the Jefferies Global Healthcare Conference 2026
DMAC : NASDAQ
Business Wire
DiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial
DMAC : NASDAQ
Business Wire
DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
DMAC : NASDAQ
Motley Fool
DiaMedica (DMAC) Q1 2026 Earnings Transcript
DMAC : NASDAQ
SeekingAlpha
DiaMedica outlines ReMEDy2 interim analysis by end of 2026 with potential 300-700 patient resample size
DMAC : NASDAQ
SeekingAlpha
DiaMedica Therapeutics Inc. (DMAC) Q1 2026 Earnings Call Transcript
DMAC : NASDAQ
SeekingAlpha
DiaMedica Therapeutics GAAP EPS of -$0.19 misses by $0.01
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.